- Home
- ALHC vs LGND Comparison
ALHC vs LGND Comparison
Compare ALHC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALHC
- LGND
- Stock Information
- Founded
- ALHC 2013
- LGND 1987
- Country
- ALHC United States
- LGND United States
- Employees
- ALHC N/A
- LGND 68
- Industry
- ALHC Medical Specialities
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- ALHC Health Care
- LGND Health Care
- Exchange
- ALHC Nasdaq
- LGND Nasdaq
- Market Cap
- ALHC 2.7B
- LGND 3.2B
- IPO Year
- ALHC 2021
- LGND 1992
- Fundamental
- Price
- ALHC $17.59
- LGND $186.98
- Analyst Decision
- ALHC Buy
- LGND Strong Buy
- Analyst Count
- ALHC 11
- LGND 8
- Target Price
- ALHC $18.50
- LGND $144.71
- AVG Volume (30 Days)
- ALHC 2.4M
- LGND 139.7K
- Earning Date
- ALHC 10-30-2025
- LGND 08-05-2025
- Dividend Yield
- ALHC N/A
- LGND N/A
- EPS Growth
- ALHC N/A
- LGND N/A
- EPS
- ALHC N/A
- LGND N/A
- Revenue
- ALHC $3,335,894,000.00
- LGND $181,488,000.00
- Revenue This Year
- ALHC $47.21
- LGND $18.41
- Revenue Next Year
- ALHC $28.24
- LGND $18.87
- P/E Ratio
- ALHC N/A
- LGND N/A
- Revenue Growth
- ALHC 49.46
- LGND 53.40
- 52 Week Low
- ALHC $10.18
- LGND $81.74
- 52 Week High
- ALHC $21.06
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- ALHC 57.64
- LGND 67.50
- Support Level
- ALHC $16.99
- LGND $179.00
- Resistance Level
- ALHC $17.75
- LGND $187.81
- Average True Range (ATR)
- ALHC 0.49
- LGND 5.10
- MACD
- ALHC -0.05
- LGND -0.42
- Stochastic Oscillator
- ALHC 65.53
- LGND 78.61
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.